B-Cell Lymphoma, Unspecified
2 clinical trials · Condition
◉ Watch B-Cell Lymphoma, Unspecified
| Record | Firm | Date |
|---|---|---|
| Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT02992522) | Beth Christian | 2017-02-21 |
Track B-Cell Lymphoma, Unspecified automatically
Every clearance here is in the API, with alerts when new ones post.